Tubular dysfunction and non-albuminuric renal disease in subjects with type 2 diabetes mellitus

被引:1
作者
Ludivina Robles-Osorio, Ma. [1 ]
Sabath, Ernesto [2 ]
机构
[1] Univ Autonoma Queretaro, Santiago De Queretaro, Mexico
[2] Hosp Gen Queretaro, Dept Nefrol, Zaragoza, Spain
来源
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | 2014年 / 66卷 / 03期
关键词
alpha; 1-microglobulin; Diabetic nephropathy; Albuminuria; INJURY MOLECULE-1 KIM-1; RISK-FACTORS; ENDOTHELIAL DYSFUNCTION; FUNCTION DECLINE; LIPOCALIN NGAL; NEPHROPATHY; MICROALBUMINURIA; ATHEROSCLEROSIS; BIOMARKERS; MARKER;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Micro-albuminuria is considered an early marker of glomerular injury in patients with diabetes but it has yet to be determined whether testing for markers of tubular injury can also identify people who are at risk of progressive renal disease. Objective. To evaluate markers of tubular injury and renal characteristics in a sample of community treated type 2 diabetic subjects. Material and methods. We carry-out an assessment of a group of community diabetic patients, anthropometric measures, creatinine clearance, HbA1c, lipid profile, the mean fast serum glucose levels, albuminuria and alpha 1-microglobulin (alpha 1M) urine excretion were evaluated. Results. From 95 included patients, 45.2% had alpha 1M urinary excretion >= 10 mu g/gCr, 23.1% micro-albuminuria, 9.6% macro-albuminuria and 27.2% had a GFR < 60 mL/min. The most important risk factor associated with a1M excretion was fasting glucose level (OR 4.3, 95IC 1.7-11.1 p = 0.001); HbA1c >= 8% and age were the most important risk factors associated with GFR <= 60 mL/min. Most of patients had uncontrolled glucose levels and 45.1% patients with albuminuria were not receiving any drug with anti-proteinuric effects. Conclusions. Fasting glucose levels was the most important risk factor associated with tubular dysfunction; non-albuminuric presentation of CKD defined as GFR < 60 mL/min was frequent in our population, so is necessary to implement different strategies for surveillance in patients with type 2 diabetes aiming to delay progression to CKD.
引用
收藏
页码:234 / 239
页数:6
相关论文
共 27 条
[1]   Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64) [J].
Adler, AI ;
Stevens, RJ ;
Manley, SE ;
Bilous, RW ;
Cull, CA ;
Holman, RR .
KIDNEY INTERNATIONAL, 2003, 63 (01) :225-232
[2]   Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM-1) as Predictors of Incident CKD Stage 3: The Atherosclerosis Risk in Communities (ARIC) Study [J].
Bhavsar, Nrupen A. ;
Koettgen, Anna ;
Coresh, Josef ;
Astor, Brad C. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 60 (02) :233-240
[3]   Renal lipid metabolism and lipotoxicity [J].
Bobulescu, Ion Alexandru .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2010, 19 (04) :393-402
[4]   Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients [J].
Cardoso, Claudia R. L. ;
Ferreira, Marcel T. ;
Leite, Nathalie C. ;
Barros, Pablo N. ;
Conte, Paulo H. ;
Salles, Gil F. .
ATHEROSCLEROSIS, 2009, 205 (02) :472-476
[5]   Analysis of population survey for determining the factors associated with the control of diabetes mellitus in Mexico [J].
Claudio Hernandez-Romieu, Alfonso ;
Elnecave-Olaiz, Alejandro ;
Huerta-Uribe, Nidia ;
Reynoso-Noveron, Nancy .
SALUD PUBLICA DE MEXICO, 2011, 53 (01) :34-39
[6]   Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors [J].
Conway, Bryan R. ;
Manoharan, Deepika ;
Manoharan, Divya ;
Jenks, Sara ;
Dear, James W. ;
McLachlan, Stela ;
Strachan, Mark W. J. ;
Price, Jackie F. .
KIDNEY INTERNATIONAL, 2012, 82 (07) :812-818
[7]   Early detection and prevention of diabetic nephropathy:: A challenge calling for mandatory action for Mexico and the developing world [J].
Correa-Rotter, R ;
González-Michaca, L .
KIDNEY INTERNATIONAL, 2005, 68 :S69-S75
[8]   Detection of early nephropathy in Mexican patients with type 2 diabetes mellitus [J].
Cueto-Manzano, AM ;
Cortes-Sanabria, L ;
Martinez-Ramirez, HR ;
Rojas-Campos, E ;
Barragan, G ;
Alfaro, G ;
Flores, J ;
Anaya, M ;
Canales-Munoz, JL .
KIDNEY INTERNATIONAL, 2005, 68 :S40-S45
[9]   Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy [J].
de Zeeuw, D ;
Remuzzi, G ;
Parving, HH ;
Keane, WF ;
Zhang, ZX ;
Shahinfar, S ;
Snapinn, S ;
Cooper, ME ;
Mitch, WE ;
Brenner, BM .
CIRCULATION, 2004, 110 (08) :921-927
[10]   Biomarkers in chronic kidney disease: a review [J].
Fassett, Robert G. ;
Venuthurupalli, Sree K. ;
Gobe, Glenda C. ;
Coombes, Jeff S. ;
Cooper, Matthew A. ;
Hoy, Wendy E. .
KIDNEY INTERNATIONAL, 2011, 80 (08) :806-821